Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume 52, Issue 7, Pages 1313-1322
Publisher
Oxford University Press (OUP)
Online
2013-03-30
DOI
10.1093/rheumatology/ket129
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases
- (2011) P. Engel et al. PHARMACOLOGICAL REVIEWS
- Measuring outcomes in systemic lupus erythematosus clinical trials
- (2011) Vibeke Strand et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Systemic Lupus Erythematosus
- (2010) Erez Ben-Menachem ANESTHESIA AND ANALGESIA
- Advances in drug therapy for systemic lupus erythematosus
- (2010) Daniel J Wallace BMC Medicine
- The management of systemic lupus erythematosus: Facts and controversies
- (2010) Daniel Elbirt et al. CLINICS IN DERMATOLOGY
- B cells as therapeutic targets in SLE
- (2010) Iñaki Sanz et al. Nature Reviews Rheumatology
- Targeting B cells in immune-mediated inflammatory disease: A comprehensive review of mechanisms of action and identification of biomarkers
- (2010) Thomas Dörner et al. PHARMACOLOGY & THERAPEUTICS
- Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus
- (2010) Capucine Daridon et al. ARTHRITIS RESEARCH & THERAPY
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Why can't we find a new treatment for SLE?
- (2009) Robert Eisenberg JOURNAL OF AUTOIMMUNITY
- B-cell-depletion therapy in SLE—what are the current prospects for its acceptance?
- (2009) Catarina Favas et al. Nature Reviews Rheumatology
- Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus
- (2009) Guillermo J. Pons-Estel et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- CD22: an inhibitory enigma
- (2008) Jennifer A. Walker et al. IMMUNOLOGY
- Systemic Lupus Erythematosus
- (2008) Anisur Rahman et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now